Share price of Aurobindo Pharma rose 2 percent intraday Tuesday on USFDA approval for Meropenem Injection. The company has received final approval from the US Food & Drug Administration (USFDA) to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback